Aegis Downgrades Inovio (INO) to Hold; Keeping an Eye on VGX-3100 Ph. 2 Data
Tweet Send to a Friend
Aegis Capital downgraded Inovio Pharmaceuticals, Inc. (AMEX: INO) from Buy to Hold today, maintaining a 12-month price target of $1.50.
This article: 206 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 206 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
